-
-
-
-
-
-
-
NeoGenomics Completes Acquisition of Pathline
-
-
-
-
-
-
-
NeoGenomics Reports Fourth Quarter and Full Year 2023 Results
-
-
-
-
-
-
-
NeoGenomics Reports Third Quarter 2022 Results
-
-
-
-
-
-
-
NeoGenomics (NEO) Announces CEO Departure, Sees Q1 Results Below Prior Guidance, Withdraws 2022 Guidance
-
-
-
-
-
-
-
Guardant Health (GH) Said to Decide Against NeoGenomics (NEO) Takeover - Bloomberg
-
-
-
-
-
-
-
NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform
-
-
-
-
-
-
-
NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

